What’s New

News

May 10, 2024

Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease Week (DDW) Meeting…

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

Publication

Feb 1, 2022

Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis

Arjan Bredenoord, Brian Feagan, Christopher Ma, Evan Dellon, Guangyong Zou, Lisa M Shackelton, Stefanie C McFarlane, Vipul Jairath.

Publication

Jan 25, 2022

Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials

Christopher Ma, Malcolm Hogan, Rocio Sedano, Vipul Jairath.

Publication

Jan 18, 2022

Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease

Brian Feagan, Christopher Ma, Rocio Sedano, Vipul Jairath.

News

Jan 17, 2022

Implementation of Histopathology in GI Clinical Trials

Join our expert panel where they will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four exp…

Publication

Jan 16, 2022

Design of Clinical Trials for Mild to Moderate Ulcerative Colitis

Rocio Sedano, Vipul Jairath.

Publication

Jan 3, 2022

A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease

Brian Feagan, Niels Vande Casteele, Vipul Jairath.